Global Gastrointestinal Drugs Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Gastrointestinal Drugs market size will reach 49,726 Million USD in 2025 and is projected to reach 68,673 Million USD by 2032, with a CAGR of 4.72% (2025-2032). Notably, the China Gastrointestinal Drugs market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Gastrointestinal (GI) drugs are medications designed to treat disorders and diseases affecting the digestive system, which includes the stomach, intestines, and associated organs. These drugs address a wide range of conditions such as acid reflux, peptic ulcers, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), constipation, diarrhea, and nausea. Common classes of GI drugs include antacids, proton pump inhibitors (PPIs), H2-receptor antagonists, laxatives, antidiarrheals, antiemetics, and antispasmodics. For instance, antacids and PPIs are used to reduce stomach acid and relieve symptoms of heartburn and acid reflux, while laxatives help alleviate constipation by promoting bowel movements. These medications can be available over-the-counter or by prescription, depending on their strength and specific use. Gastrointestinal drugs play a crucial role in improving the quality of life for patients by managing symptoms, promoting healing, and preventing complications associated with GI disorders.
The major global manufacturers of Gastrointestinal Drugs include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria (Tillotts), Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gastrointestinal Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastrointestinal Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gastrointestinal Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastrointestinal Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gastrointestinal Drugs Include:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Gastrointestinal Drugs Product Segment Include:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Gastrointestinal Drugs Product Application Include:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gastrointestinal Drugs Industry PESTEL Analysis
Chapter 3: Global Gastrointestinal Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Gastrointestinal Drugs Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Gastrointestinal Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Gastrointestinal Drugs Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gastrointestinal Drugs Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Gastrointestinal Drugs market size will reach 49,726 Million USD in 2025 and is projected to reach 68,673 Million USD by 2032, with a CAGR of 4.72% (2025-2032). Notably, the China Gastrointestinal Drugs market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Gastrointestinal (GI) drugs are medications designed to treat disorders and diseases affecting the digestive system, which includes the stomach, intestines, and associated organs. These drugs address a wide range of conditions such as acid reflux, peptic ulcers, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), constipation, diarrhea, and nausea. Common classes of GI drugs include antacids, proton pump inhibitors (PPIs), H2-receptor antagonists, laxatives, antidiarrheals, antiemetics, and antispasmodics. For instance, antacids and PPIs are used to reduce stomach acid and relieve symptoms of heartburn and acid reflux, while laxatives help alleviate constipation by promoting bowel movements. These medications can be available over-the-counter or by prescription, depending on their strength and specific use. Gastrointestinal drugs play a crucial role in improving the quality of life for patients by managing symptoms, promoting healing, and preventing complications associated with GI disorders.
The major global manufacturers of Gastrointestinal Drugs include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria (Tillotts), Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gastrointestinal Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastrointestinal Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gastrointestinal Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastrointestinal Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gastrointestinal Drugs Include:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Gastrointestinal Drugs Product Segment Include:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Gastrointestinal Drugs Product Application Include:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Gastrointestinal Drugs Industry PESTEL Analysis
Chapter 3: Global Gastrointestinal Drugs Industry Porter's Five Forces Analysis
Chapter 4: Global Gastrointestinal Drugs Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Gastrointestinal Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Gastrointestinal Drugs Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Gastrointestinal Drugs Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Gastrointestinal Drugs Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gastrointestinal Drugs Product by Type
- 1.2.1 Prescription Gastrointestinal Drug
- 1.2.2 OTC Gastrointestinal Drug
- 1.3 Gastrointestinal Drugs Product by Application
- 1.3.1 Chronic Gastritis
- 1.3.2 Functional Dyspepsia
- 1.3.3 Peptic Ulcer
- 1.3.4 Acute Gastroenteritis
- 1.3.5 Others
- 1.4 Global Gastrointestinal Drugs Market Revenue and Sales Analysis
- 1.4.1 Global Gastrointestinal Drugs Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Gastrointestinal Drugs Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Gastrointestinal Drugs Market Sales Price Trend Analysis (2020-2032)
- 1.5 Gastrointestinal Drugs Market Development Status and Trends
- 1.5.1 Gastrointestinal Drugs Industry Development Status Analysis
- 1.5.2 Gastrointestinal Drugs Industry Development Trends Analysis
- 2 Gastrointestinal Drugs Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gastrointestinal Drugs Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gastrointestinal Drugs Market Analysis by Country
- 4.1 Global Gastrointestinal Drugs Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Gastrointestinal Drugs Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Gastrointestinal Drugs Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Gastrointestinal Drugs Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Gastrointestinal Drugs Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Gastrointestinal Drugs Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Gastrointestinal Drugs Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Gastrointestinal Drugs Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Gastrointestinal Drugs Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Gastrointestinal Drugs Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Gastrointestinal Drugs Average Sales Price by Manufacturers (2021-2025)
- 5.2 Gastrointestinal Drugs Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Gastrointestinal Drugs Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Gastrointestinal Drugs Market Analysis by Type
- 6.1 Global Gastrointestinal Drugs Market Revenue Analysis by Type
- 6.1.1 Global Gastrointestinal Drugs Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Gastrointestinal Drugs Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Gastrointestinal Drugs Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Gastrointestinal Drugs Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 AstraZeneca
- 7.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 AstraZeneca Gastrointestinal Drugs Product Portfolio
- 7.1.3 AstraZeneca Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Sanofi
- 7.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Sanofi Gastrointestinal Drugs Product Portfolio
- 7.2.3 Sanofi Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Bayer
- 7.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Bayer Gastrointestinal Drugs Product Portfolio
- 7.3.3 Bayer Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Pfizer
- 7.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Pfizer Gastrointestinal Drugs Product Portfolio
- 7.4.3 Pfizer Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 GlaxoSmithKline
- 7.5.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
- 7.5.3 GlaxoSmithKline Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Teva
- 7.6.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Teva Gastrointestinal Drugs Product Portfolio
- 7.6.3 Teva Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Zeria (Tillotts)
- 7.7.1 Zeria (Tillotts) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
- 7.7.3 Zeria (Tillotts) Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Perrigo
- 7.8.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Perrigo Gastrointestinal Drugs Product Portfolio
- 7.8.3 Perrigo Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Boehringer Ingelheim
- 7.9.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
- 7.9.3 Boehringer Ingelheim Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Purdue Pharma
- 7.10.1 Purdue Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Purdue Pharma Gastrointestinal Drugs Product Portfolio
- 7.10.3 Purdue Pharma Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 C.B. Fleet
- 7.11.1 C.B. Fleet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 C.B. Fleet Gastrointestinal Drugs Product Portfolio
- 7.11.3 C.B. Fleet Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 Abbott
- 7.12.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Abbott Gastrointestinal Drugs Product Portfolio
- 7.12.3 Abbott Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Jiangzhong
- 7.13.1 Jiangzhong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Jiangzhong Gastrointestinal Drugs Product Portfolio
- 7.13.3 Jiangzhong Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.14 Xian-Janssen
- 7.14.1 Xian-Janssen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Xian-Janssen Gastrointestinal Drugs Product Portfolio
- 7.14.3 Xian-Janssen Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Gastrointestinal Drugs Industry Chain Analysis
- 8.2 Gastrointestinal Drugs Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Gastrointestinal Drugs Product Downstream Application Analysis
- 8.3.1 Global Gastrointestinal Drugs Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Gastrointestinal Drugs Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Gastrointestinal Drugs Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Gastrointestinal Drugs Typical Downstream Customers
- 8.5 Gastrointestinal Drugs Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
